Literature DB >> 22332205

ω-3 intake and visual acuity in patients with retinitis pigmentosa receiving vitamin A.

Eliot L Berson1, Bernard Rosner, Michael A Sandberg, Carol Weigel-DiFranco, Walter C Willett.   

Abstract

OBJECTIVE: To evaluate whether a diet high in long chain ω-3 fatty acids can slow the rate of visual acuity loss among patients with retinitis pigmentosa receiving vitamin A palmitate.
METHODS: We calculated dietary intake from questionnaires completed annually by 357 adult patients from 3 randomized trials who were all receiving vitamin A, 15 000 IU/d, for 4 to 6 years. Rates of visual acuity decline were compared between those with high (≥0.20 g/d) vs low (<0.20 g/d) ω-3 intake. Analyses took age into account.
RESULTS: Mean rates of decline of acuity were slower among those with high ω-3 intake: Early Treatment Diabetic Retinopathy Study distance acuity: high intake=0.59 letter per year, low intake=1.00 letter per year,P=.001; Snellen retinal acuity: high intake=1.5% per year, low intake=2.8% per year, P=.03.
CONCLUSIONS: We conclude that mean annual rates of decline in distance and retinal visual acuities in adults with retinitis pigmentosa receiving vitamin A, 15 000 IU/d,are slower over 4 to 6 years among those consuming a diet rich in ω-3 fatty acids. To our knowledge, this is the first report that nutritional intake can modify the rate of decline of visual acuity in retinitis pigmentosa.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22332205      PMCID: PMC3552384          DOI: 10.1001/archophthalmol.2011.2580

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  19 in total

1.  The use of a self-administered questionnaire to assess diet four years in the past.

Authors:  W C Willett; L Sampson; M L Browne; M J Stampfer; B Rosner; C H Hennekens; F E Speizer
Journal:  Am J Epidemiol       Date:  1988-01       Impact factor: 4.897

Review 2.  Retinitis pigmentosa. The Friedenwald Lecture.

Authors:  E L Berson
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-04       Impact factor: 4.799

3.  New visual acuity charts for clinical research.

Authors:  F L Ferris; A Kassoff; G H Bresnick; I Bailey
Journal:  Am J Ophthalmol       Date:  1982-07       Impact factor: 5.258

4.  Prevalence of retinitis pigmentosa and allied disorders in Denmark. I Main results.

Authors:  M Haim; N V Holm; T Rosenberg
Journal:  Acta Ophthalmol (Copenh)       Date:  1992-04

5.  Natural course of retinitis pigmentosa over a three-year interval.

Authors:  E L Berson; M A Sandberg; B Rosner; D G Birch; A H Hanson
Journal:  Am J Ophthalmol       Date:  1985-03-15       Impact factor: 5.258

6.  Prevalence of retinitis pigmentosa in Maine.

Authors:  C H Bunker; E L Berson; W C Bromley; R P Hayes; T H Roderick
Journal:  Am J Ophthalmol       Date:  1984-03       Impact factor: 5.258

7.  Potential acuity meter using a minute aerial pinhole aperture.

Authors:  J S Minkowski; M Palese; D L Guyton
Journal:  Ophthalmology       Date:  1983-11       Impact factor: 12.079

8.  Fatty acid composition of subcutaneous adipose tissue and diet in postmenopausal US women.

Authors:  S J London; F M Sacks; J Caesar; M J Stampfer; E Siguel; W C Willett
Journal:  Am J Clin Nutr       Date:  1991-08       Impact factor: 7.045

9.  Rates of change differ among measures of visual function in patients with retinitis pigmentosa.

Authors:  K Holopigian; V Greenstein; W Seiple; R E Carr
Journal:  Ophthalmology       Date:  1996-03       Impact factor: 12.079

10.  A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa.

Authors:  E L Berson; B Rosner; M A Sandberg; K C Hayes; B W Nicholson; C Weigel-DiFranco; W Willett
Journal:  Arch Ophthalmol       Date:  1993-06
View more
  29 in total

Review 1.  Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy.

Authors:  A Guzman-Aranguez; P Loma; J Pintor
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

2.  Docosahexaenoic Acid Slows Visual Field Progression in X-Linked Retinitis Pigmentosa: Ancillary Outcomes of the DHAX Trial.

Authors:  Dennis R Hoffman; Dianna K Hughbanks-Wheaton; Rand Spencer; Gary E Fish; N Shirlene Pearson; Yi-Zhong Wang; Martin Klein; Alison Takacs; Kirsten G Locke; David G Birch
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-10       Impact factor: 4.799

Review 3.  Antioxidants and vision health: facts and fiction.

Authors:  Ashok K Grover; Sue E Samson
Journal:  Mol Cell Biochem       Date:  2013-12-06       Impact factor: 3.396

Review 4.  Stem cell transplantation as a progressing treatment for retinitis pigmentosa.

Authors:  Sedighe Hosseini Shabanan; Homa Seyedmirzaei; Alona Barnea; Sara Hanaei; Nima Rezaei
Journal:  Cell Tissue Res       Date:  2022-01-10       Impact factor: 5.249

5.  Whole genome sequencing in patients with retinitis pigmentosa reveals pathogenic DNA structural changes and NEK2 as a new disease gene.

Authors:  Koji M Nishiguchi; Richard G Tearle; Yangfan P Liu; Edwin C Oh; Noriko Miyake; Paola Benaglio; Shyana Harper; Hanna Koskiniemi-Kuendig; Giulia Venturini; Dror Sharon; Robert K Koenekoop; Makoto Nakamura; Mineo Kondo; Shinji Ueno; Tetsuhiro R Yasuma; Jacques S Beckmann; Shiro Ikegawa; Naomichi Matsumoto; Hiroko Terasaki; Eliot L Berson; Nicholas Katsanis; Carlo Rivolta
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

6.  Receptor interacting protein kinase mediates necrotic cone but not rod cell death in a mouse model of inherited degeneration.

Authors:  Yusuke Murakami; Hidetaka Matsumoto; Miin Roh; Jun Suzuki; Toshio Hisatomi; Yasuhiro Ikeda; Joan W Miller; Demetrios G Vavvas
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

7.  The relationship of central foveal thickness to urinary iodine concentration in retinitis pigmentosa with or without cystoid macular edema.

Authors:  Michael A Sandberg; Elizabeth N Pearce; Shyana Harper; Carol Weigel-DiFranco; Lois Hart; Bernard Rosner; Eliot L Berson
Journal:  JAMA Ophthalmol       Date:  2014-10       Impact factor: 7.389

8.  Safety assessment of docosahexaenoic acid in X-linked retinitis pigmentosa: the 4-year DHAX trial.

Authors:  Dianna K Hughbanks-Wheaton; David G Birch; Gary E Fish; Rand Spencer; N Shirlene Pearson; Alison Takacs; Dennis R Hoffman
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-07-11       Impact factor: 4.799

Review 9.  Anthocyanin can arrest the cone photoreceptor degeneration and act as a novel treatment for retinitis pigmentosa.

Authors:  Ye Tao; Tao Chen; Guo-Qing Yang; Guang-Hua Peng; Zhong-Jun Yan; Yi-Fei Huang
Journal:  Int J Ophthalmol       Date:  2016-01-18       Impact factor: 1.779

10.  Presumed neuroprotective therapies prescribed by veterinary ophthalmologists for canine degenerative retinal and optic nerve diseases.

Authors:  Ryan G Hopper; Fabiano Montiani-Ferreira; Jorge da Silva Pereira; Michele C Fritz; Vickie J Ruggiero; John S Sapienza; Kumiko Kato; András M Komáromy
Journal:  Vet Ophthalmol       Date:  2021-03-07       Impact factor: 1.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.